Global and Japan Carcinoembryonic Antigen (CEA) Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 CD66a
1.2.3 CD66b
1.2.4 CD66c
1.2.5 CD66d
1.2.6 CD66e
1.2.7 CD66f
1.3 Market by Application
1.3.1 Global Carcinoembryonic Antigen (CEA) Market Share by Application: 2020 VS 2026
1.3.2 Colorectal Cancer
1.3.3 Pancreatic Cancer
1.3.4 Ovarian Cancer
1.3.5 Breast Cancer
1.3.6 Thyroid Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Carcinoembryonic Antigen (CEA) Market Perspective (2015-2026)
2.2 Global Carcinoembryonic Antigen (CEA) Growth Trends by Regions
2.2.1 Carcinoembryonic Antigen (CEA) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Carcinoembryonic Antigen (CEA) Historic Market Share by Regions (2015-2020)
2.2.3 Carcinoembryonic Antigen (CEA) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Carcinoembryonic Antigen (CEA) Players by Market Size
3.1.1 Global Top Carcinoembryonic Antigen (CEA) Players by Revenue (2015-2020)
3.1.2 Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Players (2015-2020)
3.2 Global Carcinoembryonic Antigen (CEA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Carcinoembryonic Antigen (CEA) Revenue
3.4 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio
3.4.1 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carcinoembryonic Antigen (CEA) Revenue in 2019
3.5 Key Players Carcinoembryonic Antigen (CEA) Area Served
3.6 Key Players Carcinoembryonic Antigen (CEA) Product Solution and Service
3.7 Date of Enter into Carcinoembryonic Antigen (CEA) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Carcinoembryonic Antigen (CEA) Breakdown Data by Type (2015-2026)
4.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Type (2015-2020)
4.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Type (2021-2026)
5 Carcinoembryonic Antigen (CEA) Breakdown Data by Application (2015-2026)
5.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Application (2015-2020)
5.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Carcinoembryonic Antigen (CEA) Market Size (2015-2026)
6.2 North America Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
6.3 North America Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
6.4 North America Carcinoembryonic Antigen (CEA) Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Carcinoembryonic Antigen (CEA) Market Size (2015-2026)
7.2 Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
7.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
7.4 Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Carcinoembryonic Antigen (CEA) Market Size (2015-2026)
8.2 China Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
8.3 China Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
8.4 China Carcinoembryonic Antigen (CEA) Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Carcinoembryonic Antigen (CEA) Market Size (2015-2026)
9.2 Japan Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
9.3 Japan Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
9.4 Japan Carcinoembryonic Antigen (CEA) Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (2015-2026)
10.2 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
10.3 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
10.4 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Carcinoembryonic Antigen (CEA) Introduction
11.1.4 Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020))
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott Diagnostics
11.2.1 Abbott Diagnostics Company Details
11.2.2 Abbott Diagnostics Business Overview
11.2.3 Abbott Diagnostics Carcinoembryonic Antigen (CEA) Introduction
11.2.4 Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020)
11.2.5 Abbott Diagnostics Recent Development
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Details
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Carcinoembryonic Antigen (CEA) Introduction
11.3.4 Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020)
11.3.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of CD66a
Table 4. Key Players of CD66b
Table 5. Key Players of CD66c
Table 6. Key Players of CD66d
Table 7. Key Players of CD66e
Table 8. Key Players of CD66f
Table 9. Global Carcinoembryonic Antigen (CEA) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Carcinoembryonic Antigen (CEA) Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Carcinoembryonic Antigen (CEA) Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Carcinoembryonic Antigen (CEA) Market Share by Regions (2015-2020)
Table 13. Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Carcinoembryonic Antigen (CEA) Market Share by Regions (2021-2026)
Table 15. Carcinoembryonic Antigen (CEA) Market Market Trends
Table 16. Carcinoembryonic Antigen (CEA) Market Drivers
Table 17. Carcinoembryonic Antigen (CEA) Market Challenges
Table 18. Carcinoembryonic Antigen (CEA) Market Restraints
Table 19. Global Carcinoembryonic Antigen (CEA) Revenue by Players (2015-2020) (US$ Million)
Table 20. Global Carcinoembryonic Antigen (CEA) Market Share by Players (2015-2020)
Table 21. Global Top Carcinoembryonic Antigen (CEA) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoembryonic Antigen (CEA) as of 2019)
Table 22. Global Carcinoembryonic Antigen (CEA) by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Carcinoembryonic Antigen (CEA) Product Solution and Service
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (US$ Million)
Table 27. Global Carcinoembryonic Antigen (CEA) Market Size Share by Type (2015-2020)
Table 28. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Type (2021-2026)
Table 29. Global Carcinoembryonic Antigen (CEA) Market Size Share by Application (2015-2020)
Table 30. Global Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (US$ Million)
Table 31. Global Carcinoembryonic Antigen (CEA) Market Size Share by Application (2021-2026)
Table 32. North America Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (US$ Million)
Table 33. North America Carcinoembryonic Antigen (CEA) Market Share by Type (2015-2020)
Table 34. North America Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (US$ Million)
Table 35. North America Carcinoembryonic Antigen (CEA) Market Share by Application (2015-2020)
Table 36. North America Carcinoembryonic Antigen (CEA) Market Size by Country (US$ Million) (2015-2020)
Table 37. North America Carcinoembryonic Antigen (CEA) Market Share by Country (2015-2020)
Table 38. Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (US$ Million)
Table 39. Europe Carcinoembryonic Antigen (CEA) Market Share by Type (2015-2020)
Table 40. Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (US$ Million)
Table 41. Europe Carcinoembryonic Antigen (CEA) Market Share by Application (2015-2020)
Table 42. Europe Carcinoembryonic Antigen (CEA) Market Size by Country (US$ Million) (2015-2020)
Table 43. Europe Carcinoembryonic Antigen (CEA) Market Share by Country (2015-2020)
Table 44. China Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (US$ Million)
Table 45. China Carcinoembryonic Antigen (CEA) Market Share by Type (2015-2020)
Table 46. China Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (US$ Million)
Table 47. China Carcinoembryonic Antigen (CEA) Market Share by Application (2015-2020)
Table 48. China Carcinoembryonic Antigen (CEA) Market Size by Region (US$ Million) (2015-2020)
Table 49. China Carcinoembryonic Antigen (CEA) Market Share by Region (2015-2020)
Table 50. Japan Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (US$ Million)
Table 51. Japan Carcinoembryonic Antigen (CEA) Market Share by Type (2015-2020)
Table 52. Japan Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (US$ Million)
Table 53. Japan Carcinoembryonic Antigen (CEA) Market Share by Application (2015-2020)
Table 54. Japan Carcinoembryonic Antigen (CEA) Market Size by Country (US$ Million) (2015-2020)
Table 55. Japan Carcinoembryonic Antigen (CEA) Market Share by Country (2015-2020)
Table 56. Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (US$ Million)
Table 57. Southeast Asia Carcinoembryonic Antigen (CEA) Market Share by Type (2015-2020)
Table 58. Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (US$ Million)
Table 59. Southeast Asia Carcinoembryonic Antigen (CEA) Market Share by Application (2015-2020)
Table 60. Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Country (US$ Million) (2015-2020)
Table 61. Southeast Asia Carcinoembryonic Antigen (CEA) Market Share by Country (2015-2020)
Table 62. Roche Diagnostics Company Details
Table 63. Roche Diagnostics Business Overview
Table 64. Roche Diagnostics Product
Table 65. Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020) (US$ Million)
Table 66. Roche Diagnostics Recent Development
Table 67. Abbott Diagnostics Company Details
Table 68. Abbott Diagnostics Business Overview
Table 69. Abbott Diagnostics Product
Table 70. Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020) (US$ Million)
Table 71. Abbott Diagnostics Recent Development
Table 72. Quest Diagnostics Company Details
Table 73. Quest Diagnostics Business Overview
Table 74. Quest Diagnostics Product
Table 75. Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020) (US$ Million)
Table 76. Quest Diagnostics Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Carcinoembryonic Antigen (CEA) Market Share by Type: 2020 VS 2026
Figure 2. CD66a Features
Figure 3. CD66b Features
Figure 4. CD66c Features
Figure 5. CD66d Features
Figure 6. CD66e Features
Figure 7. CD66f Features
Figure 8. Global Carcinoembryonic Antigen (CEA) Market Share by Application: 2020 VS 2026
Figure 9. Colorectal Cancer Case Studies
Figure 10. Pancreatic Cancer Case Studies
Figure 11. Ovarian Cancer Case Studies
Figure 12. Breast Cancer Case Studies
Figure 13. Thyroid Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Carcinoembryonic Antigen (CEA) Report Years Considered
Figure 16. Global Carcinoembryonic Antigen (CEA) Market Size (US$ Million), YoY Growth 2015-2026
Figure 17. Global Carcinoembryonic Antigen (CEA) Market Share by Regions: 2020 VS 2026
Figure 18. Global Carcinoembryonic Antigen (CEA) Market Share by Regions (2021-2026)
Figure 19. Global Carcinoembryonic Antigen (CEA) Market Share by Players in 2019
Figure 20. Global Top Carcinoembryonic Antigen (CEA) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoembryonic Antigen (CEA) as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Carcinoembryonic Antigen (CEA) Revenue in 2019
Figure 22. North America Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. United States Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Canada Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Europe Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Germany Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. France Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. U.K. Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Italy Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Russia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Nordic Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Europe Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. China Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Japan Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. South Korea Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Southeast Asia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. India Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Australia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Latin America Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Mexico Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Brazil Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Turkey Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Saudi Arabia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. UAE Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Rest of Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 49. Roche Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2015-2020)
Figure 50. Abbott Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2015-2020)
Figure 51. Quest Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed